Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Medi Assist Ser. Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Expansion of technology-led revenue streams, especially from SaaS products like MAtrix and AI-driven solutions such as MAven Guard, with tech revenues growing…
25 Aug 2026
Rashi Peripheral Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Overall long-term volume growth is guided around 8% to 10% Y-o-Y aligned with GDP growth, economy, digitalization, and low PC penetration. Key concall…
25 Aug 2026
Dev Accele. Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The company plans expansion predominantly in Tier 2 cities, maintaining a 70%-30% revenue split between Tier 2 and Tier 1 cities. Key concall takeaways from…
25 Aug 2026
Ganesh Consumer Products Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
January month showed a strong volume growth of ~9% in B2C category, indicating positive momentum (Pages 13,16,17). Key concall takeaways from Ganesh Consumer…
25 Aug 2026
Kalpat. Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
52,000 crores, providing strong visibility for sustained growth. Key concall takeaways from Kalpat.'s Q3 FY26 earnings call — and how it ranks against sector…
25 Aug 2026
Shadowfax Technologies Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Hyperlocal segment (17% of revenues) grew 43% year-on-year and continues to expand rapidly with traction in quick commerce categories like baby wear, apparel…
25 Aug 2026
DEE Development Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
450 crore. Key concall takeaways from DEE Development's Q3 FY26 earnings call — and how it ranks against sector peers.
25 Aug 2026
Aster DM Quality Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
25 Aug 2026
Restaurant Brand Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Focus on profitable growth, especially by reducing delivery discounts and improving gross margins, which have already reached 70%, ahead of schedule. Key…
25 Aug 2026
BMW Industries Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The transition to an integrated downstream processing model will increase raw material costs but drive top-line expansion and PAT growth in the range of…
25 Aug 2026
Chandan Healthcare Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
25 Aug 2026
Elin Electronics Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Growth across segments is shifting: motors now contribute ~17-18%, while lighting, fans, and appliances remain primary drivers. Key concall takeaways from Elin…
25 Aug 2026
Fine Organic Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Investment of approximately INR 700-750 crores for Phase 1. Key concall takeaways from Fine Organic's Q3 FY26 earnings call — and how it ranks against sector…
25 Aug 2026
Parth Electricals & Engineering Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Combined, both new facilities can add around INR 300 crores to top-line revenue at full capacity. Key concall takeaways from Parth Electricals & Engineering…
25 Aug 2026
Dhabriya Polywood Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Plan to improve capacity utilization from 50-60% to over 66% and further to 85% to reach INR450 crores revenue in profile extrusion by FY28 (Page 6, 15). Key…
25 Aug 2026
Piccadily Agro Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
IMFL segment driving majority of growth, with 63% quarterly and ~31% annualized growth currently. Key concall takeaways from Piccadily Agro's Q4 FY26 earnings…
25 Aug 2026
Patel Integrated Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
The company is focusing on profitable growth, with total income from operations growing by 11.68% YoY to INR 96.74 crore in Q4 FY '26. Key concall takeaways…
25 Aug 2026
Torrent Pharma. Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Consolidated revenue for Q4 FY26 up 42%, EBITDA up 41%, margins stable at ~32% (Page 2). Key concall takeaways from Torrent Pharma.'s Q4 FY26 earnings call…
25 Aug 2026
Om Power Transmission Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
FY26 year-end unexecuted order book stood at INR 621 crores, an all-time high, over 3x FY23 level and 41% higher than FY25 closing. Key concall takeaways from…
25 Aug 2026
Kwality Pharmaceuticals Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
FY26: Achieved INR503 crores revenue; oncology contributed INR100-120 crores. Key concall takeaways from Kwality Pharmaceuticals Ltd's Q4 FY26 earnings call…
25 Aug 2026